Global and China Cervus and Cucumis Polypeptide Market, 2010-2019 - Global Trends, Capacity, Generation, Investment Trends, Regulations and Company ProfilesPharmaceutical ResearchUpdated on Aug 25, 2016 View more like this | Visit SAN FRANCISCO, CA | Contact market reports center |
According to statistics, the incidence of rheumatoid arthritis (RA) is 0.2%-0.36% and the number of cases is 5-10 million in China. With the ageing population in China, over 60% of elder people aged above 60 suffer from osteoarthritis, says a study. Patients with osteoarthritis typically show reduced mobility and life quality caused by joint pain, malformation and joint dysfunction.
First developed by Gloria Pharmaceuticals Co., Ltd, cervus and cucumis polypeptide is a sterile water solution made of extracted bones of Cervus Nippon Temmick and the dry mature seeds of Cucumis melo L. And it works well in rheumatism, RA, early healing of fracture, osteoarthritis, pain in waist and lower extremities as well as wound recovery.
Request sample at : https://marketreportscenter.com/request-sample/133413
Cervus and cucumis polypeptide develops fast after entering China, annual sales value rising from less than CNY 10 million in 2006 to CNY 310 million in 2014 and CAGR during this period exceeding 50%. Currently, cervus and cucumis polypeptide in the Chinese market all come from the following three companies: Gloria Pharmaceuticals Co., Ltd, Heilongjiang Dilong Pharmaceutical Co., Ltd and Heilongjiang Jiangshi Pharmaceutical Co., Ltd, among which Gloria Pharmaceuticals Co., Ltd has the largest market share of over 80% for sales value in 2014.
The ageing population in China keeps growing, people aged 60 and above amounting to 212.42 million and occupying 15.5% of the total population while people aged 65 and above amounting to 137.55 million and occupying 10.1% of the total population by the end of 2014. With the ageing population, the incidence of RA will continue to grow. Therefore the market size of cervus and cucumis polypeptide is expected to keep expanding in the next few years in China.
Check for Discount at : https://marketreportscenter.com/request-discount/133413
Readers can get at least the following information from this report:
-market size of cervus and cucumis polypeptide in China
-competitive landscape of cervus and cucumis polypeptide in Chinese market
-price of cervus and cucumis polypeptide made by different enterprises in China
-market outlook of cervus and cucumis polypeptide in China
The author suggests the following groups of people purchase this report:
-manufacturers of RA drugs
-investors/ research institutions interested in Chinese medicine market
-any interest in the Chinese medicine market, please contact CRI for customized survey service
Browse full report with TOC : https://marketreportscenter.com/reports/133413/investigation-report-on-china-cervus-and-cucumis-polypeptide-market-2010-2019
Connect for more details:
Sam Collins
Market Reports Center
Call us : 1-646-883-3044 (US)
Email : [email protected]
visit our website : https://marketreportscenter.com
First developed by Gloria Pharmaceuticals Co., Ltd, cervus and cucumis polypeptide is a sterile water solution made of extracted bones of Cervus Nippon Temmick and the dry mature seeds of Cucumis melo L. And it works well in rheumatism, RA, early healing of fracture, osteoarthritis, pain in waist and lower extremities as well as wound recovery.
Request sample at : https://marketreportscenter.com/request-sample/133413
Cervus and cucumis polypeptide develops fast after entering China, annual sales value rising from less than CNY 10 million in 2006 to CNY 310 million in 2014 and CAGR during this period exceeding 50%. Currently, cervus and cucumis polypeptide in the Chinese market all come from the following three companies: Gloria Pharmaceuticals Co., Ltd, Heilongjiang Dilong Pharmaceutical Co., Ltd and Heilongjiang Jiangshi Pharmaceutical Co., Ltd, among which Gloria Pharmaceuticals Co., Ltd has the largest market share of over 80% for sales value in 2014.
The ageing population in China keeps growing, people aged 60 and above amounting to 212.42 million and occupying 15.5% of the total population while people aged 65 and above amounting to 137.55 million and occupying 10.1% of the total population by the end of 2014. With the ageing population, the incidence of RA will continue to grow. Therefore the market size of cervus and cucumis polypeptide is expected to keep expanding in the next few years in China.
Check for Discount at : https://marketreportscenter.com/request-discount/133413
Readers can get at least the following information from this report:
-market size of cervus and cucumis polypeptide in China
-competitive landscape of cervus and cucumis polypeptide in Chinese market
-price of cervus and cucumis polypeptide made by different enterprises in China
-market outlook of cervus and cucumis polypeptide in China
The author suggests the following groups of people purchase this report:
-manufacturers of RA drugs
-investors/ research institutions interested in Chinese medicine market
-any interest in the Chinese medicine market, please contact CRI for customized survey service
Browse full report with TOC : https://marketreportscenter.com/reports/133413/investigation-report-on-china-cervus-and-cucumis-polypeptide-market-2010-2019
Connect for more details:
Sam Collins
Market Reports Center
Call us : 1-646-883-3044 (US)
Email : [email protected]
visit our website : https://marketreportscenter.com
